Shepherd Therapeutics is a Massachusetts-based biopharmaceutical company that researches treatments for rare cancers. Its filings show it lobbies Congress about federal budgets and health policy—seeking funding and awareness for rare cancer research—and also listed issues tied to defense and veterans. It reported no spending in the filings available.
Show the dominant industry call, how mixed the client looks, and the allocation across the top labeled sectors.
Annual totals based on disclosed filing amounts.
Issue rankings are based on disclosed activity mentions, with filing amounts apportioned evenly across issues within the same filing.
The lobbying registrants handling this client, ranked by disclosed filing amounts.
Lobbyists are ranked by appearances and an equal share of each filing's reported amount.
ELIZABETH POWELL
The latest disclosures for this client.
G2G CONSULTING
Q1G2G CONSULTING
Q4The entities named in disclosed activities are the clearest available signal for where the client is aiming attention.
G2G CONSULTING
KATHERINE M COLLINS
G2G CONSULTING
mr ADITYA GIRISH phd
G2G CONSULTING
mr CHRISTOPHER WILLIAM COOPER
G2G CONSULTING
G2G CONSULTING
Q3G2G CONSULTING
Q2G2G CONSULTING
Q1